Aisling Capital as of Dec. 31, 2014
Portfolio Holdings for Aisling Capital
Aisling Capital holds 19 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Esperion Therapeutics (ESPR) | 12.6 | $83M | 2.1M | 40.44 | |
| Cempra | 11.7 | $77M | 3.3M | 23.51 | |
| Zeltiq Aesthetics | 11.0 | $73M | 2.6M | 27.91 | |
| Chimerix (CMRX) | 9.3 | $61M | 1.5M | 40.26 | |
| Catalent | 7.4 | $49M | 1.8M | 27.88 | |
| T2 Biosystems | 7.4 | $49M | 2.5M | 19.24 | |
| Versartis | 6.8 | $45M | 2.0M | 22.45 | |
| Loxo Oncology | 6.2 | $41M | 3.5M | 11.75 | |
| Adma Biologics (ADMA) | 6.1 | $40M | 3.6M | 11.17 | |
| Paratek Pharmaceuticals | 4.0 | $26M | 683k | 38.55 | |
| Transenterix | 3.7 | $24M | 8.3M | 2.91 | |
| Dermira | 3.0 | $20M | 1.1M | 18.11 | |
| Pernix Therapeutics Holdings | 2.9 | $19M | 2.0M | 9.39 | |
| Sorrento Therapeutics (SRNE) | 2.7 | $18M | 1.8M | 10.07 | |
| Agile Therapeutics | 2.0 | $13M | 2.2M | 6.14 | |
| Intersect Ent | 1.0 | $6.5M | 350k | 18.55 | |
| Lombard Med (EVARF) | 0.9 | $5.8M | 886k | 6.50 | |
| Roka Bioscience | 0.8 | $4.9M | 1.1M | 4.41 | |
| Mei Pharma | 0.7 | $4.3M | 1.0M | 4.27 |
